Search research articles
Contact Us
Filters
Showing results (281-290 of 344) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study
Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, et al.
Lancet (London, England)
|
June 9, 2018
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara, Mustafa Özgüroğlu, Yung-Jue Bang, et al.
Lancet (London, England)
|
April 17, 2023
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
Kohei Shitara, Florian Lordick, Yung-Jue Bang, et al.
Lancet (London, England)
|
October 23, 2023
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Yelena Y Janjigian, Akihito Kawazoe, Yuxian Bai, et al.
The Oncologist
|
December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
Yeon Hee Park, Javier Cortes, Shanu Modi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer
Akinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 1, 2021
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Charles S Fuchs, Mustafa Özgüroğlu, Yung-Jue Bang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2022
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
Keun-Wook Lee, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2023
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
Giovanni Randon, Yu Aoki, Romain Cohen, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 344) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study
Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, et al.
Lancet (London, England)
|
June 9, 2018
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara, Mustafa Özgüroğlu, Yung-Jue Bang, et al.
Lancet (London, England)
|
April 17, 2023
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
Kohei Shitara, Florian Lordick, Yung-Jue Bang, et al.
Lancet (London, England)
|
October 23, 2023
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Yelena Y Janjigian, Akihito Kawazoe, Yuxian Bai, et al.
The Oncologist
|
December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
Yeon Hee Park, Javier Cortes, Shanu Modi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer
Akinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 1, 2021
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Charles S Fuchs, Mustafa Özgüroğlu, Yung-Jue Bang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2022
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
Keun-Wook Lee, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2023
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
Giovanni Randon, Yu Aoki, Romain Cohen, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Page
of 35